Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

Bone destruction induced by the metastasis of breast cancer cells is a frequent complication that is caused by the interaction between cancer cells and bone cells. Receptor activator of nuclear factor kappa-B ligand (RANKL) and the endogenous soluble RANKL inhibitor, osteoprotegerin (OPG), directly...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sun Kyoung, Park, Kwang-Kyun, Kim, Ki Rim, Kim, Hyun-Jeong, Chung, Won-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699756/
https://www.ncbi.nlm.nih.gov/pubmed/26734591
http://dx.doi.org/10.15430/JCP.2015.20.4.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699756/
https://www.ncbi.nlm.nih.gov/pubmed/26734591
http://dx.doi.org/10.15430/JCP.2015.20.4.281

Ejemplares similares